These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 25483909)

  • 1. Prospective, observational real-life study on eligibility for and outcomes of antiviral treatment with peginterferon α plus ribavirin in chronic hepatitis C.
    Vukotic R; Gamal N; Andreone P
    Dig Liver Dis; 2015 Feb; 47(2):151-6. PubMed ID: 25483909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defer or treat? Reasons for treatment decisions in patients with chronic hepatitis C genotype 1 in the early era of directly acting antiviral agents.
    Kittner JM; Weiss NM; Wiltink J; Schattenberg JM; Grambihler A; Thieringer F; Weinmann A; Zimmermann T; Koch S; Schuchmann M; Galle PR
    Dig Liver Dis; 2014 Jan; 46(1):67-71. PubMed ID: 24125691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical management of a patient with drug dependence who attempted suicide while receiving peginterferon therapy for chronic hepatitis C.
    Fábregas BC; Moura AS; Marciano RC; Carmo RA; Teixeira AL
    Braz J Infect Dis; 2009 Oct; 13(5):387-90. PubMed ID: 20428642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Reasons for not initating HCV treatment in prison: a subanalysis of the EPIBAND study].
    de Juan J; Faraco I; Saiz de la Hoya P; Marco A; Yllobre C; Da Silva A; del Pozo E; Veiras FM;
    Rev Esp Sanid Penit; 2011; 13(2):44-51. PubMed ID: 21750854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perceived barriers to hepatitis C therapy for patients receiving opioid agonist treatment.
    Zickmund SL; Campbell SA; Tirado CF; Zook CL; Weinrieb RM
    J Addict Med; 2012 Sep; 6(3):233-9. PubMed ID: 22790464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic hepatitis C: treat or wait? A prospective study on reasons for treatment or nontreatment in the era of first-generation protease inhibitors.
    Feillant M; Jézéquel C; Lison H; Delluc A; Tanné F; Le Gruyer A; Ben Ali Z; Renard I; Latournerie M; Deugnier Y; Garioud A; Cadranel JF; Guyader D; Robaszkiewicz M; Nousbaum JB
    Eur J Gastroenterol Hepatol; 2016 Feb; 28(2):164-72. PubMed ID: 26560750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C treatment of veterans with psychiatric illness.
    Rifai MA; Loftis JM; Hauser P
    Am J Gastroenterol; 2006 Mar; 101(3):673-4; author reply 674-5. PubMed ID: 16542298
    [No Abstract]   [Full Text] [Related]  

  • 8. A randomized controlled trial of an integrated care intervention to increase eligibility for chronic hepatitis C treatment.
    Evon DM; Simpson K; Kixmiller S; Galanko J; Dougherty K; Golin C; Fried MW
    Am J Gastroenterol; 2011 Oct; 106(10):1777-86. PubMed ID: 21769136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reasons to wait or to treat naive patients affected by chronic hepatitis C with low fibrosis stage and genotypes 2 or 3.
    Boglione L; Cusato J; Cariti G; Di Perri G; D'Avolio A
    Eur J Public Health; 2017 Oct; 27(5):938-941. PubMed ID: 28340198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. When to treat patients with chronic hepatitis C.
    Heathcote J; Ramji A
    Curr Gastroenterol Rep; 2004 Aug; 6(4):261-3. PubMed ID: 15245691
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of pediatric hepatitis C: results and perspectives.
    Vegnente A; Iorio R; Pensati P
    Acta Gastroenterol Belg; 1998; 61(2):235-6. PubMed ID: 9658618
    [No Abstract]   [Full Text] [Related]  

  • 12. Rate and factors affecting treatment uptake of patients with chronic hepatitis C in a tertiary referral hospital.
    Yan KK; Wong GL; Wong VW; Chan HL
    Dig Dis Sci; 2010 Dec; 55(12):3541-7. PubMed ID: 20927593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barriers to HCV treatment in the era of triple therapy: a prospective multi-centred study in clinical practice.
    Crespo J; Cabezas J; Sacristán B; Olcoz JL; Pérez R; De la Vega J; García R; García-Pajares F; Sáez-Royuela F; González JM; Jiménez F; Rodríguez S; Cuadrado A; López-Arias MJ; García I; Milla A; García-Riesco E; Muñoz M; Sánchez-Antolín G; Jorquera F
    Liver Int; 2015 Feb; 35(2):401-8. PubMed ID: 24650000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A descriptive evaluation of eligibility for therapy among veterans with chronic hepatitis C virus infection.
    Muir AJ; Provenzale D
    J Clin Gastroenterol; 2002 Mar; 34(3):268-71. PubMed ID: 11873110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Editorial: Direct Antiviral Agents Eliminate the Age Barrier to Treatment of Chronic Hepatitis C.
    Koff RS
    Am J Gastroenterol; 2017 Sep; 112(9):1410-1411. PubMed ID: 28874853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thiazolides: a new class of antiviral drugs.
    Rossignol JF
    Expert Opin Drug Metab Toxicol; 2009 Jun; 5(6):667-74. PubMed ID: 19442032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PITER: An ongoing nationwide study on the real-life impact of direct acting antiviral based treatment for chronic hepatitis C in Italy.
    Kondili LA; Vella S;
    Dig Liver Dis; 2015 Sep; 47(9):741-3. PubMed ID: 26138800
    [No Abstract]   [Full Text] [Related]  

  • 18. Regional differences in treatment rates for patients with chronic hepatitis C infection: Systematic review and meta-analysis.
    Vutien P; Jin M; Le MH; Nguyen P; Trinh S; Huang JF; Yu ML; Chuang WL; Nguyen MH
    PLoS One; 2017; 12(9):e0183851. PubMed ID: 28877190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New, Expensive Treatments for Chronic Hepatitis C: Insuring Good Outcomes?
    Goldhaber-Fiebert JD
    Dig Dis Sci; 2015 Nov; 60(11):3153-4. PubMed ID: 26386855
    [No Abstract]   [Full Text] [Related]  

  • 20. Non-atherosclerotic cardiac manifestations of chronic hepatitis C virus infection in the era of direct-acting antiviral agents.
    Karimi-Sari H; Rezaee-Zavareh MS
    Atherosclerosis; 2020 Apr; 298():70. PubMed ID: 32147149
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.